Company: OSRH
Filing Date: 2025-08-19
Form Type: PRE 14A
Source: 0001213900-25-078140
Chunk: 34

Company: OSR Holdings, Inc.
Filing Date: 2025-08-19
Form: PRE 14A
Chunk 34
---
 income equal to the fair market value of the shares or
cash received. The Company is generally entitled to a deduction equal to the income recognized.

Section 409A

To the extent any awards under the Omnibus Plan are subject
to Section 409A of the Code (nonqualified deferred compensation), the awards must comply with Section 409A’s rules on deferral elections
and distributions to avoid the imposition of additional taxes and penalties. The Company intends that awards under the Omnibus Plan will
either comply with or be exempt from Section 409A.

Tax Deductibility under Section 162(m)

Under Section 162(m) of the Code, the Company’s deduction
for compensation paid to certain covered employees (generally, the CEO, CFO, and the next three highest-paid executives) is limited to
$1 million per year per covered employee, regardless of whether such compensation is performance-based. Although the Omnibus Plan permits
the granting of performance-based awards, no assurance can be given that any compensation will be deductible.

Vote Required and Board of Directors’ Recommendation

The approval of the Equity Plan Proposal requires the affirmative
vote of the majority of the votes cast by stockholders represented in person or by proxy at the Annual Meeting. Broker non-votes and
abstentions will not be taken into account in determining the outcome of the proposal. The Board recommends that stockholders vote “FOR” the Equity Plan Proposal.

<div align='center'>18

NASDAQ 20% ISSUANCE PROPOSAL</div>

Overview

The Nasdaq 20% Issuance Proposal is for the shareholders
to approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 20% or more of our issued and outstanding
common stock to White Lion GBM Innovation Fund and/or its affiliates (“White Lion”). It is anticipated that such level
of equity issuance may be met or exceeded in accordance with the exercise by the Board of the Company’s rights to sell company common
shares to White Lion pursuant to that certain common stock equity line agreement by and between the Company and White Lion consisting
of a Common Stock Purchase Agreement and a Registration Rights Agreement both dated as of February 25, 2025 as amended and restated as
of May 6, 2025, (collectively, the “ELOC Agreement”), establishing an “equity line” of investment (“ELOC”),
in combination with the potential exercise by White Lion of its rights under the WL Warrant Agreement and